Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002054793-25-000001
Filing Date
2025-05-22
Accepted
2025-05-22 15:02:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2885
  Complete submission text file 0002054793-25-000001.txt   4578
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Subject) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-27055 | Film No.: 25976531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address HAMAGAL 10/14 KIRYAT ONO L3 55402-05
Business Address
Tal Amir David (Reporting) CIK: 0002054793 (see all company filings)

Type: 144